Literature DB >> 23322563

Gastrostomy tube placement in patients with oropharyngeal carcinoma treated with radiotherapy or chemoradiotherapy: factors affecting placement and dependence.

Mihir K Bhayani1, Katherine A Hutcheson, Denise A Barringer, Asher Lisec, Clare P Alvarez, Dianna B Roberts, Stephen Y Lai, Jan S Lewin.   

Abstract

BACKGROUND: Although many patients require nutritional support during radiotherapy or chemoradiotherapy for oropharyngeal cancer, little is known regarding the risk factors that predispose to gastrostomy tube (g-tube) placement and prolonged dependence, or the therapeutic interventions that may abrogate these effects.
METHODS: We performed a retrospective medical chart review of patients who were treated for primary oropharyngeal cancer at a tertiary care center from 2003 to 2008. Patients who had a complete response at the primary site at 1-year posttreatment were included. G-tube placement and dependence ≥6 months were evaluated in relationship to site and stage of primary tumor, baseline characteristics, treatment type, smoking status, and swallowing intervention.
RESULTS: We evaluated 474 patients (79%) with oropharyngeal cancer; 215 patients (40%) had concurrent chemotherapy, 73 patients (15%) had induction chemotherapy, and 69 patients (15%) had induction chemotherapy followed by concurrent chemotherapy. Two hundred ninety-three patients (62%) received g-tubes, of which 238 (81%) received the g-tube during radiation. At 1-year follow-up, 41 patients (9%) remained dependent on enteral feedings. Placement of g-tubes and prolonged g-tube dependence were significantly more likely in patients with T3 to 4 tumors (p < .001), baseline self-reported dysphagia (p < .001), odynophagia (p < .001), >10% baseline weight loss (p < .001), and in those treated with concurrent chemoradiotherapy. Patients who reported adherence to exercises had significantly lower rates of g-tube placement (p < .001), and duration of dependence was significantly shorter in those who reported adherence to swallowing exercises (p < .001).
CONCLUSION: Almost 40% of patients with oropharyngeal cancer treated with nonsurgical organ preservation modalities may avoid feeding tube placement. Factors that predispose to g-tube placement and prolonged dependence include T3 to T4 tumors, concurrent chemotherapy, current smoking status, and baseline swallowing dysfunction or weight loss. Adherence to an aggressive swallowing regimen may reduce long-term dependence on enteral nutrition and limit the rate of g-tube placement overall.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  dysphagia; gastrostomy tube; oropharynx; radiation therapy; speech pathology

Mesh:

Year:  2013        PMID: 23322563     DOI: 10.1002/hed.23200

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  33 in total

1.  Trends in the 15D health-related quality of life over the first year following diagnosis of head and neck cancer.

Authors:  K Aro; L Bäck; V Loimu; K Saarilahti; S Rogers; H Sintonen; R Roine; Antti Mäkitie
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-07-28       Impact factor: 2.503

2.  Primary radical ablative surgery and fibula free-flap reconstruction for T4 oral cavity squamous cell carcinoma with mandibular invasion: oncologic and functional results and their predictive factors.

Authors:  Olivier Camuzard; Olivier Dassonville; Marc Ettaiche; Emmanuel Chamorey; Gilles Poissonnet; Riadh Berguiga; Axel Leysalle; Karen Benezery; Frédéric Peyrade; Esma Saada; Raphael Hechema; Anne Sudaka; Juliette Haudebourg; François Demard; José Santini; Alexandre Bozec
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-07-20       Impact factor: 2.503

3.  Long-term quality of life after swallowing and salivary-sparing chemo-intensity modulated radiation therapy in survivors of human papillomavirus-related oropharyngeal cancer.

Authors:  Jeffrey M Vainshtein; Dominic H Moon; Felix Y Feng; Douglas B Chepeha; Avraham Eisbruch; Matthew H Stenmark
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-04-01       Impact factor: 7.038

4.  Letter to the Editor regarding transoral laser microsurgery followed by radiotherapy in advanced oropharyngeal cancer.

Authors:  Adam S Garden; Clifton D Fuller
Journal:  Head Neck       Date:  2014-09-25       Impact factor: 3.147

5.  Pretreatment factors associated with functional oral intake and feeding tube use at 1 and 6 months post-radiotherapy (+/- chemotherapy) for head and neck cancer.

Authors:  Molly K Barnhart; Elizabeth C Ward; Bena Cartmill; Rachelle A Robinson; Virginia A Simms; Sophie J Chandler; Elea T Wurth; Robert I Smee
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-08-06       Impact factor: 2.503

6.  18F-FDG Metabolic Tumor Volume: Association with Short- and Long-Term Feeding Tube Use in Head and Neck IMRT.

Authors:  James E Jackson; Nigel J Anderson; Maureen Rolfo; Morikatsu Wada; Michal Schneider; Michael Poulsen; Maziar Fahandej; Anna Huynh; Sze Ting Lee; Daryl Lim Joon; Vincent Khoo
Journal:  Dysphagia       Date:  2018-09-28       Impact factor: 3.438

7.  Reduced feeding tube duration with intensity-modulated radiation therapy for head and neck cancer: A Surveillance, Epidemiology, and End Results-Medicare Analysis.

Authors:  Beth M Beadle; Kai-Ping Liao; Sharon H Giordano; Adam S Garden; Katherine A Hutcheson; Stephen Y Lai; B Ashleigh Guadagnolo
Journal:  Cancer       Date:  2016-09-23       Impact factor: 6.860

8.  Feeding Tube Utilization in Patients with Salivary Gland Malignancies.

Authors:  Diane Wenhua Chen; Jan S Lewin; Li Xu; Stephen Y Lai; G Brandon Gunn; Clifton David Fuller; Abdallah S R Mohamed; Aasheesh Kanwar; Erich M Sturgis; Katherine A Hutcheson
Journal:  Otolaryngol Head Neck Surg       Date:  2016-10-03       Impact factor: 3.497

9.  The natural history of weight and swallowing outcomes in oropharyngeal cancer patients following radiation or concurrent chemoradiation therapy.

Authors:  Nedeljko Jovanovic; Colleen Dreyer; Sarah Hawkins; Kendra Thouless; David Palma; Philip C Doyle; Julie A Theurer
Journal:  Support Care Cancer       Date:  2020-08-01       Impact factor: 3.603

10.  Intensity-modulated proton beam therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for patients with oropharynx cancer - A case matched analysis.

Authors:  Pierre Blanchard; Adam S Garden; G Brandon Gunn; David I Rosenthal; William H Morrison; Mike Hernandez; Joseph Crutison; Jack J Lee; Rong Ye; C David Fuller; Abdallah S R Mohamed; Kate A Hutcheson; Emma B Holliday; Nikhil G Thaker; Erich M Sturgis; Merrill S Kies; X Ronald Zhu; Radhe Mohan; Steven J Frank
Journal:  Radiother Oncol       Date:  2016-06-21       Impact factor: 6.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.